Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Harris

Showing results (51-60 of 314) with videos related to

Pageof 32
Sort By:
JAMA|March 24, 2025
Autosomal Dominant Polycystic Kidney Disease: A ReviewFouad T Chebib, Christian Hanna, Peter C Harris, et al.
The Journal of Clinical Investigation|January 10, 2015
Polycystin-1 maturation requires polycystin-2 in a dose-dependent mannerVladimir G Gainullin, Katharina Hopp, Christopher J Ward, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 30, 2018
Population data improves variant interpretation in autosomal dominant polycystic kidney diseaseAmali C Mallawaarachchi, Timothy J Furlong, John Shine, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 10, 2020
Biallelic inheritance of hypomorphic PKD1 variants is highly prevalent in very early onset polycystic kidney diseaseMiranda Durkie, Jiehan Chong, Manoj K Valluru, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 15, 2025
GLP-1RA Semaglutide Delays the Progression of ADPKD Through Regulation of Glycolysis, Mitochondria Function and KetosisJiao Wu, Alice Shasha Cheng, Thomas Weimbs, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 18, 2024
How We Treat Primary Hyperoxaluria Type 1Matthew C Breeggemann, Peter C Harris, John C Lieske, et al.
Journal of Cellular Physiology|August 3, 2006
Functional characterization of PKDREJ, a male germ cell-restricted polycystinKeith A Sutton, Melissa K Jungnickel, Christopher J Ward, et al.
Gastroenterology|March 27, 2007
Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphateTatyana V Masyuk, Anatoliy I Masyuk, Vicente E Torres, et al.
Nature Medicine|March 3, 2004
Effective treatment of an orthologous model of autosomal dominant polycystic kidney diseaseVicente E Torres, Xiaofang Wang, Qi Qian, et al.
The Journal of Urology|August 2, 2024
The Evolving Role of Genetic Testing in Monogenic Kidney Stone Disease: Spotlight on Primary HyperoxaluriaMatthew C Breeggemann, Peter C Harris, John C Lieske, et al.
Pageof 32

Showing results (51-60 of 314) with videos related to

Sort By:
Pageof 32
JAMA|March 24, 2025
Autosomal Dominant Polycystic Kidney Disease: A ReviewFouad T Chebib, Christian Hanna, Peter C Harris, et al.
The Journal of Clinical Investigation|January 10, 2015
Polycystin-1 maturation requires polycystin-2 in a dose-dependent mannerVladimir G Gainullin, Katharina Hopp, Christopher J Ward, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 30, 2018
Population data improves variant interpretation in autosomal dominant polycystic kidney diseaseAmali C Mallawaarachchi, Timothy J Furlong, John Shine, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 10, 2020
Biallelic inheritance of hypomorphic PKD1 variants is highly prevalent in very early onset polycystic kidney diseaseMiranda Durkie, Jiehan Chong, Manoj K Valluru, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 15, 2025
GLP-1RA Semaglutide Delays the Progression of ADPKD Through Regulation of Glycolysis, Mitochondria Function and KetosisJiao Wu, Alice Shasha Cheng, Thomas Weimbs, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 18, 2024
How We Treat Primary Hyperoxaluria Type 1Matthew C Breeggemann, Peter C Harris, John C Lieske, et al.
Journal of Cellular Physiology|August 3, 2006
Functional characterization of PKDREJ, a male germ cell-restricted polycystinKeith A Sutton, Melissa K Jungnickel, Christopher J Ward, et al.
Gastroenterology|March 27, 2007
Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphateTatyana V Masyuk, Anatoliy I Masyuk, Vicente E Torres, et al.
Nature Medicine|March 3, 2004
Effective treatment of an orthologous model of autosomal dominant polycystic kidney diseaseVicente E Torres, Xiaofang Wang, Qi Qian, et al.
The Journal of Urology|August 2, 2024
The Evolving Role of Genetic Testing in Monogenic Kidney Stone Disease: Spotlight on Primary HyperoxaluriaMatthew C Breeggemann, Peter C Harris, John C Lieske, et al.
Pageof 32